© Copyright Acquisition International 2026 - All Rights Reserved.

Article Image - OPKO Health Acquires EirGen Pharma
Posted 28th May 2015

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

OPKO Health Acquires EirGen Pharma

OPKO Health Acquires EirGen Pharma

View Biography
Image

Paul Heffernan, Legal Adviser OPKO Health

OPKO Health, Inc. is pleased to announce the acquisition of EirGen Pharma, Ltd., a growing, profitable and cash flow positive specialty pharmaceutical company focused on the development and commercial supply of high potency, high barrier to entry, pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world.

EirGen, based in Waterford, Ireland, was founded by two former executives of IVAX Pharmaceuticals, Tom Brennan and Patsy Carney. The company, situated in a state of the art high containment research and development, and manufacturing facility, is approved by the FDA, EMEA (European Health Authorities) and the PMDA (Japanese Health Authorities). High potency drugs such as those used for cancer chemotherapy are typically unsuitable for manufacture in normal multi-product facilities due to cross contamination risks.

To date, EirGen and its commercial partners have filed 10 product applications with the FDA and 5 each in Europe and Japan. EirGen has a strong research and development portfolio of over 20 niche, high barrier to entry drugs and, with access to additional capital that OPKO will provide, together with the benefits of Irish government programs to encourage research and development in Ireland, EirGen will rapidly expand its drug portfolio.

“EirGen Pharma is one of the leading developers and suppliers of high potency niche pharmaceutical products in the world,” said Phillip Frost, M.D. OPKO’s Chairman and CEO. “As FineTech, OPKO’s Israeli active pharmaceutical ingredient manufacturing subsidiary, is also focused on high potency drugs, an immediate business synergy is expected. EirGen also offers the significant benefit of potentially being able to manufacture OPKO’s current and future products in our own facilities, which we expect will result in even higher gross margins. The superb management, research and development, manufacturing and product distribution teams, along with state of the art facilities, together, will create an important, tax efficient base of operations for OPKO,” said Dr. Frost.

Categories: M&A, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Are Your Business and Personal Brands Prepared for AI? Expert Says Most Aren’t
Innovation
28/04/2023Are Your Business and Personal Brands Prepared for AI? Expert Says Most Aren’t

The online competition for attention and engagement has never been more intense. And the rapid rise of AI is exponentially increasing the tension, bringing things to a game-changing level. To stand out from the crowd and compete, leaders need to get their pers

Read Full PostRead - Eye Icon
4 Experts You Need on Board to Successfully Get Your Startup Off the Ground
Finance
03/03/20204 Experts You Need on Board to Successfully Get Your Startup Off the Ground

Getting your small business off the ground is a trying time. You have already invested a lot of time and energy into making your dream of being an entrepreneur a reality, and sticking to a projected timeline is critical if you want to succeed in opening your b

Read Full PostRead - Eye Icon
Hospice Revenue Integrity: Eliminating 835 ERA Posting Errors That Distort A/R and Cash Forecasting
Technology
29/01/2026Hospice Revenue Integrity: Eliminating 835 ERA Posting Errors That Distort A/R and Cash Forecasting

Managing hospice billing can feel like trying to solve a puzzle where the pieces keep changing. Accounts receivable reports often look off, and cash forecasts never seem to match reality. Advanced RevCycle can help uncover the root of these problems by address

Read Full PostRead - Eye Icon
Immigration & EU Membership Top the List of Business Issues
Finance
22/04/2015Immigration & EU Membership Top the List of Business Issues

Research from MakeItCheaper.com suggests that business owners are more concerned with the issues of EU membership and immigration above all else. With 17 days to go until the UK general election, business owners have said what they would like to see addressed

Read Full PostRead - Eye Icon
Three Entrepreneurs Who Take Sustainability Seriously
Corporate Social Responsibility
15/11/2016Three Entrepreneurs Who Take Sustainability Seriously

In the past year, sustainability has been a growing topic of interest for businesses around the world. With the Paris Agreement fresh on people’s minds, environmental sustainability is no longer a thing of moral grounds, something simply to work towards in t

Read Full PostRead - Eye Icon
How Vendor Due Diligence Protects Your Organization
News
24/02/2025How Vendor Due Diligence Protects Your Organization

Vendors play a crucial role in an organization’s success. They provide essential products and services that offer competitive advantages, access to new technologies, and enhanced quality.   However, these relationships also come with risks that

Read Full PostRead - Eye Icon
7 Out of the Box Ways to Earn Extra Money Each Month
Finance
31/08/20227 Out of the Box Ways to Earn Extra Money Each Month

With the cost of living in the UK increasing significantly across energy, petrol and groceries, people are increasingly looking for extra work or side hustles to stay on top of their personal finances. 

Read Full PostRead - Eye Icon
2016 First Quarter Update – Haviaras & Philippou
Innovation
08/06/20162016 First Quarter Update – Haviaras & Philippou

Based in Cyprus, Haviaras & Philippou L.L.C. are a highly regarded law firm who have built their reputation through consistently providing outstanding services for their clients.

Read Full PostRead - Eye Icon
The Importance of IP in M&A transactions
Innovation
19/11/2015The Importance of IP in M&A transactions

For the past 10 years, Coller IP has been at the forefront of developments in Intangible Asset Management. Jackie Maguire profiles the firm and explains their place in the market.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow